CASTLIGHT HEALTH INC-B (CSLT)

Common Stock

2.05  +0.01 (+0.49%)

After market: 2.05 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CSLT. CSLT was compared to 40 industry peers in the Health Care Technology industry. CSLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CSLT has a expensive valuation and it also scores bad on growth.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

CSLT had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -5.25%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -6.17%
PM (TTM) -6.05%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for CSLT has been increased compared to 1 year ago.
CSLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.04 indicates that CSLT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CSLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.04
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CSLT has a Current Ratio of 2.94. This indicates that CSLT is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.94 indicates that CSLT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 2.94

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 266.67% over the past year.
The Revenue has decreased by -2.43% in the past year.
The Revenue has been growing by 14.27% on average over the past years. This is quite good.
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-50%
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y3.58%
Revenue growth 5Y14.27%
Revenue growth Q2Q-0.87%

3.2 Future

The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
Based on estimates for the next years, CSLT will show a small growth in Revenue. The Revenue will grow by 2.47% on average per year.
EPS Next Y-100%
EPS Next 2Y-64.29%
EPS Next 3Y-36.59%
EPS Next 5Y0%
Revenue Next Year-1.74%
Revenue Next 2Y0.81%
Revenue Next 3Y2.09%
Revenue Next 5Y2.47%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.00 indicates a quite expensive valuation of CSLT.
When comparing the Price/Earnings ratio of CSLT to the average of the S&P500 Index (28.28), we can say CSLT is valued slightly more expensively.
With a Price/Forward Earnings ratio of 401.96, CSLT can be considered very expensive at the moment.
When comparing the Price/Forward Earnings ratio of CSLT to the average of the S&P500 Index (20.88), we can say CSLT is valued expensively.
Industry RankSector Rank
PE 41
Fwd PE 401.96

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -118.87

4.3 Compensation for Growth

A cheap valuation may be justified as CSLT's earnings are expected to decrease with -36.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-64.29%
EPS Next 3Y-36.59%

More info and screens

0

5. Dividend

5.1 Amount

CSLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTLIGHT HEALTH INC-B

NYSE:CSLT (2/16/2022, 7:16:48 PM)

After market: 2.05 0 (0%)

2.05

+0.01 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap332.37M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 41
Fwd PE 401.96
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.25%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -6.17%
PM (TTM) -6.05%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.94
Quick Ratio 2.94
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-100%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.43%
Revenue growth 3Y3.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y